Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 20 for “"Cell replacement therapy"”.

  1. Hematopoietic stem and progenitor cells and potentials for application in fetal cell replacement therapy

    Fetal cell replacement therapy or in utero hematopoietic cell transplantation (IUHCT) is proposed as a non-myeloablative alternative to bone marrow transplantation (BMT) for a number of inborn immunologic, hematologic and metabolic disorders. IUHCT represents the method through which variable …

    lund Repository record for Hematopoietic stem and progenitor cells and potentials for application in fetal cell replacement therapy (opens in a new tab)

  2. Neural Stem Cells - interaction with the brain and prospects for cell replacement therapy for Stroke

    … as astrocytes and oligodendrocytes. Neural stem cells (NSCs) could potentially be used to develop novel therapies to restore loss of function after stroke. We generated a NSC line derived as monolayer cultures from the human fetal striatum, termed NS, and described the in vitro and in vivo …

    lund Repository record for Neural Stem Cells - interaction with the brain and prospects for cell replacement therapy for Stroke (opens in a new tab)

  3. CELL REPLACEMENT THERAPY FOR PARKINSON’S DISEASE: The importance of neuronal subtype, cell source and connectivity for functional recovery

    … therapeutic options. One such idea is cell replacement therapy (CRT). CRT aims to replace neurons that have degenerated in PD, with donor cells that have the potential to functionally re-integrate into the host circuitry. This involves transplantation of developing midbrain cells from …

    lund Repository record for CELL REPLACEMENT THERAPY FOR PARKINSON’S DISEASE: The importance of neuronal subtype, cell source and connectivity for functional recovery (opens in a new tab)

  4. Applications for human neural stem cell-derived motor neurons in amyotrophic lateral sclerosis: Cell replacement therapy and disease modeling

    … explore the potential of human fetal neural stem cells (hNSCs) to replace lost motor neurons. The therapeutic efficacy of stem cell transplantation would depend greatly on the survival of grafted stem cell-derived motor neurons in the microenvironment of the spinal cord in ALS. Previously, we …

    utmb Repository record for Applications for human neural stem cell-derived motor neurons in amyotrophic lateral sclerosis: Cell replacement therapy and disease modeling (opens in a new tab)

  5. Generation of cells for cell-replacement therapy: Specification of neural precursors in vivo and in neural stem cell cultures

    Cell replacement therapy of neurodegenerative disorders aims to substitute the degenerating cells with new functional neurons. Clinical trails with patients suffering from Parkinson’s or Huntington’s disease have generated proof-of-principle results that neural precursors taken from the developing …

    lund Repository record for Generation of cells for cell-replacement therapy: Specification of neural precursors in vivo and in neural stem cell cultures (opens in a new tab)

  6. Towards cell replacement therapy in Parkinson’s disease. Proteoglycans and Nogo-A as modulators of axonal growth in midbrain dopaminergic neurons

    … for PD are highly warranted. The concept of cell replacement therapy in PD is based on the idea that the diminished dopamine levels in the striatum would be restored by the functional DNs, obtained from donated, electively aborted fetuses, and subsequently injected into the patients’ …

    lund Repository record for Towards cell replacement therapy in Parkinson’s disease. Proteoglycans and Nogo-A as modulators of axonal growth in midbrain dopaminergic neurons (opens in a new tab)

  7. Human neural stem cells: region-specific properties and prospects for cell therapy

    Cell replacement by neural transplantation can, in animal models of neurodegenerative diseases, reconstruct damaged brain circuitry. In the clinical situation, the graft material used for cell therapy must, most likely, be of human origin. The human fetal brain is one potential source of neural …

    lund Repository record for Human neural stem cells: region-specific properties and prospects for cell therapy (opens in a new tab)

  8. Identification of dopamine neuron progenitors in the embryonic midbrain and stem cell cultures - Studies on the role of neuronal subtype and differentiation state for cell replacemen in a rodent model of Parkinson's disease

    … therapies. A promising alternative approach is cell replacement therapy, which aims to replacethe lost dopamine-producing neurons by transplanting cells with equivalent properties. Clinical transplantations using cells obtained from foetal VM tissue have provided the proof-of-principle that cell

    lund Repository record for Identification of dopamine neuron progenitors in the embryonic midbrain and stem cell cultures - Studies on the role of neuronal subtype and differentiation state for cell replacemen in a rodent model of Parkinson's disease (opens in a new tab)

  9. Stem cell-based regenerative pharmacology for the treatment of diabetes mellitus

    Stem cell-based regenerative pharmacology is aimed at establishing stem and progenitor cells as effective treatment for preventing disease and facilitating organ replacement or repair. Diabetes mellitus (DM) is a group of chronic metabolic disorders characterized by high blood glucose levels. Type …

    wfu Repository record for Stem cell-based regenerative pharmacology for the treatment of diabetes mellitus (opens in a new tab)

  10. Encapsulation as a 3D model for human embryonic stem cell propagation and differentiation

    … disease caused by the destruction of the beta cells of the pancreas. Current treatments for are whole pancreas or islet transplantation, which is limited by scarcity of cadaveric pancreata. Therefore, developing a cell replacement therapy with renewable sources of surrogate beta cells is …

    unsw Repository record for Encapsulation as a 3D model for human embryonic stem cell propagation and differentiation (opens in a new tab)

  11. Chemogenetics, Induced Neurons and Pluripotent Stem Cells: Towards Advanced Gene and Cell Therapies Targeting Epilepsy

    … the feasibility and potential for novel gene and cell therapy approaches, which hold better promise for neurological disorders, while particularly targeting epilepsy. Epilepsy is a multifactorial neurological disorder affecting 1% of the population. Available pharmacological therapies are merely …

    lund Repository record for Chemogenetics, Induced Neurons and Pluripotent Stem Cells: Towards Advanced Gene and Cell Therapies Targeting Epilepsy (opens in a new tab)

  12. A microfabricated 3-D stem cell delivery scaffold for retinal regenerative therapy

    … result in the degeneration of the photoreceptor cells and can ultimately lead to blindness in patients. There is currently no cure for AMD or RP, and only a few methods exist for slowing the progression of these diseases. Although there has been much recent headway in cell replacement therapy to …

    mit Repository record for A microfabricated 3-D stem cell delivery scaffold for retinal regenerative therapy (opens in a new tab)

  13. Targeted Epigenetic Editing to Increase Adult Pancreatic Β-Cell Proliferation

    β-cell replacement therapy is potentially a curative approach in treating diabetes, as demonstrated by the success of pancreatic islet transplantation in type 1 diabetes. However, there are an insufficient number of organ donors to meet the demand of this disease, which is increasing in prevalence. …

    penn Repository record for Targeted Epigenetic Editing to Increase Adult Pancreatic Β-Cell Proliferation (opens in a new tab)

  14. Generation of induced progenitor-like (iPL) cells using interrupted reprogramming

    … medicine is constrained by suboptimal cell sources with either limited or uncontrolled proliferation and/or incompletely restricted differentiation. We developed a novel "interrupted reprogramming" strategy without traversing the pluripotent state, to generate "induced Progenitor-Like …

    toronto-retro Repository record for Generation of induced progenitor-like (iPL) cells using interrupted reprogramming (opens in a new tab)

  15. Engineered Tracking and Delivery of Mesenchymal Stem Cells (MSCs)

    Mesenchymal stem cells (MSCs) are tissue culture plastic adherent cells that are able to differentiate into multiple cell types, modulate the immune system, and aid in wound repair. These versatile cells are thus being investigated to treat a wide variety of different diseases such as graft vs. …

    ohiolink Repository record for Engineered Tracking and Delivery of Mesenchymal Stem Cells (MSCs) (opens in a new tab)

  16. Investigating factors governing cell fate decisions in respiratory epithelium

    … embryonic development require tightly regulated cell fate decisions. This regulation takes the form of complex transcription factor and signalling cascades, much of which are unknown, particularly in human lung development. Multiciliogenesis describes the process of specification/differentiation …

    cambridge Repository record for Investigating factors governing cell fate decisions in respiratory epithelium (opens in a new tab)

  17. Generation of midbrain dopaminergic neurons in vivo and in vitro: the role of Neurogenin2

    … in PD patients. Clinical trials have shown that cell replacement therapy, where dopaminergic neuroblasts derived from fetal ventral mesencephalon (VM) are transplanted to the striatum, may be an alternative to pharmacological treatment of PD patients. The limited access and ethical concerns with …

    lund Repository record for Generation of midbrain dopaminergic neurons in vivo and in vitro: the role of Neurogenin2 (opens in a new tab)

  18. Investigating three-dimensional (3D) gelatin methacryloyl (GelMA) hydrogel as a potential scaffold for cell transplantation in Huntington's disease

    … CAG repeats that form mutant huntingtin protein. Cell replacement therapy (CRT) offers a potential pathway to treat HD by replacing the striatal neurons lost during the disease progression with healthy ones. The emergence of cell reprogramming technology offers a powerful tool to generate an …

    auckland-ms Repository record for Investigating three-dimensional (3D) gelatin methacryloyl (GelMA) hydrogel as a potential scaffold for cell transplantation in Huntington's disease (opens in a new tab)

  19. Molecular Mechanisms Involved In Krabbe's Disease

    La leucodistrofia di Krabbe o a cellule globoidi è un disturbo autosomico recessivo a carico del gene codificante per galactosilcerebrosidase (GALC). GALC è coinvolto nel catabolismo di due lipidi molto prodotti nel processo di formazione della guaina mielinica: galactosilceramide e psicosina. A …

    catania Repository record for Molecular Mechanisms Involved In Krabbe's Disease (opens in a new tab)

  20. Microscale Tissue Engineering and Contributors of the Cellular Niche

    The behaviour of cells is modulated by their microenvironment or ‘niche’. While cellular therapies offer promising curative solutions for many diseases, the efficacy of transplanted cells is often hampered by a suboptimal microenvironment. One strategy to overcome this limitation is to reconstruct …

    calgary Repository record for Microscale Tissue Engineering and Contributors of the Cellular Niche (opens in a new tab)